Drug Trial Radar · NCT07859735
A Study to Investigate the Effects of Impaired Hepatic Function on Velzatinib
Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Nov 10, 2026
Primary completion
Apr 25, 2028
Study completion Apr 25, 2028
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Oct 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study evaluates the pharmacokinetics (PK), safety, and tolerability of velzatinib in participants with mild, moderate, and severe hepatic impairment (HI) and participants with normal hepatic function.
Conditions
- Healthy Participants
- Gastrointestinal Neoplasms
Interventions
VelzatinibDrug
Velzatinib will be administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum plasma concentration (Cmax)Time frame: Up to 936 hours
- Area under the plasma concentration-time curve extrapolated to infinity AUC(0-inf)Time frame: Up to 936 hours
- Maximum plasma unbound concentration (Cmax,u)Time frame: Up to 936 hours
- Area under the unbound plasma concentration-time curve extrapolated to infinity (AUC[0-inf],u)Time frame: Up to 936 hours
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.